Volume 9, Issue 12, Pages (December 2008)

Slides:

Advertisements

Similar presentations

Perimenopausal migraine in women with vasomotor symptoms E. Anne MacGregor Maturitas Volume 71, Issue 1, Pages (January 2012) DOI: /j.maturitas

Advertisements

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta- analysis of the randomised trials The Lancet Volume 386, Issue 10001,

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Chee-Seng Tan, MRCP, David Gilligan, FRCPE, Dr Simon Pacey, FRCP

Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies Lauren J Ralph, MPH, Sandra I McCoy, PhD, Karen.

Volume 367, Issue 9517, Pages (April 2006)

Volume 361, Issue 9352, Pages (January 2003)

Volume 6, Issue 7, Pages (July 2005)

Volume 8, Issue 12, Pages (December 2007)

Volume 387, Issue 10021, Pages (February 2016)

Volume 11, Issue 4, Pages (April 2012)

Volume 16, Issue 9, Pages (September 2015)

Thank God for Richard Dawkins?

Long-term effects of hormone replacement therapy

The benefits and harms of breast cancer screening

Volume 5, Issue 4, Pages (April 2006)

Intraoperative radiotherapy for early breast cancer

Volume 366, Issue 9503, Pages (December 2005)

Volume 9, Issue 5, Pages (May 2008)

Volume 13, Issue 3, Pages (March 2012)

Long-term effects of hormone replacement therapy

Hormones and bones The Lancet Volume 349, Pages S20-S23 (March 1997)

Aspirin in the prevention of cancer – Author's reply

Volume 9, Issue 9, Pages (September 2008)

Volume 13, Issue 11, Pages (November 2012)

Volume 372, Issue 9642, Pages (September 2008)

Volume 365, Issue 9466, Pages (April 2005)

Volume 366, Issue 9484, Pages (August 2005)

INSIGHT and NORDIL The Lancet

Physiological hazards of flight at high altitude

Volume 9, Issue 10, Pages (October 2008)

Can famine relief meet health and hunger goals simultaneously?

Effects of cancer treatment during pregnancy on fetal and child development Tineke Vandenbroucke, MSc, Magali Verheecke, MD, Monica Fumagalli, MD, Christianne.

Disease and stigma The Lancet Volume 354, (December 1999)

Valerie Ann McKeon RNC, PhD

An update on Zika virus infection

Volume 386, Issue 10001, Pages (October 2015)

Crime, confidentiality, and clinical judgment

Psychological response and survival in breast cancer

The mystery of addiction

Cold water immersion: sudden death and prolonged survival

What would happen if we stopped vaccination?

Volume 11, Issue 4, Pages (April 2010)

Volume 9, Issue 9, Pages (September 2008)

Volume 14, Issue 11, Pages (October 2013)

Confessions of a journal junkie

Volume 387, Issue 10021, Pages (February 2016)

Telling it like it isn't: truth and lies in a post-9/11 world

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

Volume 9, Issue 4, Pages (April 2008)

Volume 383, Issue 9922, Pages (March 2014)

Multiple endocrine carcinomas of the ileum

Volume 15, Issue 13, Pages (December 2014)

Volume 5, Issue 4, Pages (April 2018)

Thank God for Richard Dawkins?

Volume 373, Issue 9658, Pages (January 2009)

Low-technology approaches

Prof GJB van Ommen, PhD, E Bakker, PhD, JT den Dunnen, PhD The Lancet

Volume 381, Issue 9880, Pages (May 2013)

Insulin-like growth factor-l and risk of breast cancer

Volume 11, Issue 3, Pages (March 2010)

Volume 371, Issue 9618, Pages (March 2008)

Arlene Chan, Marc Buyse, Bin Yao The Lancet Oncology

Steven A Narod The Lancet Volume 349, Issue 9068, (June 1997)

Volume 372, Issue 9632, Pages (July 2008)

Volume 12, Issue 1, Pages (January 2011)

Effect of consent rituals on mortality in emergency care research

Volume 390, Issue 10107, Pages (November 2017)

A disease of the osteoblast

Presentation transcript:

Volume 9, Issue 12, Pages 1143-1148 (December 2008) Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial Prof Jack Cuzick, PhD, Ivana Sestak, PhD, David Cella, PhD, Prof Lesley Fallowfield, PhD The Lancet Oncology Volume 9, Issue 12, Pages 1143-1148 (December 2008) DOI: 10.1016/S1470-2045(08)70259-6 Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 1 Breast cancer recurrence according to treatment group and whether joint symptoms (with or without vasomotor symptoms) were reported at the 3-month follow-up visit in women without endocrine symptoms at entry A=anastrozole. T=tamoxifen. The Lancet Oncology 2008 9, 1143-1148DOI: (10.1016/S1470-2045(08)70259-6) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 2 Breast cancer recurrence for anastrozole and tamoxifen treatments combined at different follow-up times according to endocrine symptoms reported at the 3-month follow-up visit in women with hormone-receptor-positive tumours and without endocrine symptoms at entry The Lancet Oncology 2008 9, 1143-1148DOI: (10.1016/S1470-2045(08)70259-6) Copyright © 2008 Elsevier Ltd Terms and Conditions